CHAPTER 1:INTRODUCTION
1.1.Research methodology
1.1.1.Desk research
1.1.2.Real-time insights and validation
1.1.3.Forecast model
1.1.4.Assumptions & forecast parameters
1.1.4.1.Assumptions
1.1.4.2.Forecast parameters
CHAPTER 2:EXECUTIVE SUMMARY
2.1.360° summary
2.2.Technology trends
2.3.Method trends
2.4.End user trends
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key takeaways
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.2.2.1.Top winning strategies, by year
3.2.2.2.Top winning strategies, by development
3.2.2.3.Top winning strategies, by company
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.5.Drivers
3.5.1.Government initiatives to promote non-animal alternative testing to drive the market
3.5.2.Increased research and development activities in scientific field to boost the market growth
3.6.Restraints
3.6.1.Persistent use of animal test subjects in various research fields to restrain the market growth
3.7.Opportunities
3.7.1.Increasing advancements in research and development techniques to flourish the market growth
3.8.Technology landscape
3.9.Regulatory landscape
3.10.Patent landscape
3.11.Market value chain analysis
3.12.Strategic overview
CHAPTER 4:IMPACT OF COVID-19 ON GLOBAL NON-ANIMAL ALTERNATIVE TESTING MARKET
4.1.Introduction
4.2.COVID-19 health assessment
4.3.Impact of COVID-19 on the global economy
4.4.Impact of COVID-19 on global non-animal alternative testing market
4.4.1.Social impact
4.4.2.Technological impact
4.4.3.Investment scenario
4.5.Non-animal alternative testing market size and forecast, by region, 2020-2030
CHAPTER 5:GLOBAL NON-ANIMAL ALTERNATIVE TESTING MARKET, BY TECHNOLOGY
5.1.Overview
5.1.1.Market size and forecast, by technology
5.2.Cell Culture Technology
5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country
5.3.High Throughput Technology
5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country
5.4.Molecular Imaging
5.4.1.Key market trends, growth factors and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country
5.5.Omic technology
5.5.1.Key market trends, growth factors and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market share analysis, by country
CHAPTER 6:GLOBAL NON-ANIMAL ALTERNATIVE TESTING MARKET, BY METHOD6.1.Overview
6.1.1.Market size and forecast, by method
6.2.Cellular assay
6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country
6.3.Biochemical assay
6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country
6.4.In-silico
6.4.1.Key market trends, growth factors and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market share analysis, by country
6.5.Ex-vivo
6.5.1.Key market trends, growth factors and opportunities
6.5.2.Market size and forecast, by region
6.5.3.Market share analysis, by country
CHAPTER 7:GLOBAL NON-ANIMAL ALTERNATIVE TESTING MARKET BY END-USER
7.1.Overview
7.1.1.Market size and forecast, by end user
7.2.Pharmaceutical Industry
7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market share analysis, by country
7.3.Cosmetic industry and household products
7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market share analysis, by country
7.4.Diagnostics
7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market share analysis, by country
7.5.Chemical Industry
7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by region
7.5.3.Market share analysis, by country
7.6.Food Industry
7.6.1.Key market trends, growth factors and opportunities
7.6.2.Market size and forecast, by region
7.6.3.Market share analysis, by country
CHAPTER 8:GLOBAL NON-ANIMAL ALTERNATIVE TESTING MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast, by region
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by technology
8.2.3.Market size and forecast, by method
8.2.4.Market size and forecast, by end user
8.2.5.Market size and forecast, by country
8.2.6.U.S.
8.2.6.1.Market size and forecast, by technology
8.2.6.2.Market size and forecast, by method
8.2.6.3.Market size and forecast, by end user
8.2.7.Canada
8.2.7.1.Market size and forecast, by technology
8.2.7.2.Market size and forecast, by method
8.2.7.3.Market size and forecast, by end user
8.2.8.Mexico
8.2.8.1.Market size and forecast, by technology
8.2.8.2.Market size and forecast, by method
8.2.8.3.Market size and forecast, by end user
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by technology
8.3.3.Market size and forecast, by method
8.3.4.Market size and forecast, by end user
8.3.5.Market size and forecast, by country
8.3.6.Germany
8.3.6.1.Market size and forecast, by technology
8.3.6.2.Market size and forecast, by method
8.3.6.3.Market size and forecast, by end user
8.3.7.UK
8.3.7.1.Market size and forecast, by technology
8.3.7.2.Market size and forecast, by method
8.3.7.3.Market size and forecast, by end user
8.3.8.France
8.3.8.1.Market size and forecast, by technology
8.3.8.2.Market size and forecast, by method
8.3.8.3.Market size and forecast, by end user
8.3.9.Spain
8.3.9.1.Market size and forecast, by technology
8.3.9.2.Market size and forecast, by method
8.3.9.3.Market size and forecast, by end user
8.3.10.Italy
8.3.10.1.Market size and forecast, by technology
8.3.10.2.Market size and forecast, by method
8.3.10.3.Market size and forecast, by end user
8.3.11.Rest of Europe
8.3.11.1.Market size and forecast, by technology
8.3.11.2.Market size and forecast, by method
8.3.11.3.Market size and forecast, by end user
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by technology
8.4.3.Market size and forecast, by method
8.4.4.Market size and forecast, by end user
8.4.5.Market size and forecast, by country
8.4.6.China
8.4.6.1.Market size and forecast, by technology
8.4.6.2.Market size and forecast, by method
8.4.6.3.Market size and forecast, by end user
8.4.7.Japan
8.4.7.1.Market size and forecast, by technology
8.4.7.2.Market size and forecast, by method
8.4.7.3.Market size and forecast, by end user
8.4.8.India
8.4.8.1.Market size and forecast, by technology
8.4.8.2.Market size and forecast, by method
8.4.8.3.Market size and forecast, by end user
8.4.9.South Korea
8.4.9.1.Market size and forecast, by technology
8.4.9.2.Market size and forecast, by method
8.4.9.3.Market size and forecast, by end user
8.4.10.Australia
8.4.10.1.Market size and forecast, by technology
8.4.10.2.Market size and forecast, by method
8.4.10.3.Market size and forecast, by end user
8.4.11.Rest of Asia-Pacific
8.4.11.1.Market size and forecast, by technology
8.4.11.2.Market size and forecast, by method
8.4.11.3.Market size and forecast, by end user
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by technology
8.5.3.Market size and forecast, by method
8.5.4.Market size and forecast, by end user
8.5.5.Market size and forecast, by country
8.5.6.Latin America
8.5.6.1.Market size and forecast, by technology
8.5.6.2.Market size and forecast, by method
8.5.6.3.Market size and forecast, by end user
8.5.7.Middle East
8.5.7.1.Market size and forecast, by technology
8.5.7.2.Market size and forecast, by method
8.5.7.3.Market size and forecast, by end user
8.5.8.Africa
8.5.8.1.Market size and forecast, by technology
8.5.8.2.-Market size and forecast, by method
8.5.8.3.Market size and forecast, by end user
CHAPTER 9:COMPANY PROFILES
9.1.VITROCELL SYSTEMS GMBH
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Product portfolio
9.1.4.Key strategic moves and developments
9.2.Evotec (Cryptoex Plc)
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Product portfolio
9.2.4.Key strategic moves and developments
9.3.BIOIVT
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Product portfolio
9.4.MB Research Laboratories
9.4.1.Company overview
9.4.2.Product portfolio
9.4.3.Key strategy moves and development
9.5.Emulate, Inc.
9.5.1.Company overview
9.5.2.Product portfolio
9.5.3.Key strategy moves and development
9.6.TARA Biosystems
9.6.1.Company overview
9.6.2.Operating business segments
9.6.3.Product portfolio
9.6.4.Key strategy moves and development
9.7.Bio-Rad Laboratories, Inc.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Research and Development Expenditure
9.7.6.Business performance
9.7.7.Key strategic moves and developments
9.8.HμREL CORPORATION
9.8.1.Company overview
9.8.2.Product portfolio
9.8.3.Key strategy moves and development
9.9.Abbott Laboratories
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.TissUse GmbH
9.10.1.Company overview
9.10.2.Product portfolio
9.10.3.Key strategy moves and development
PURCHASE OPTIONS
READ ONLY $2999
INDIVIDUAL USER $5700
MULTI USER $8700
BUSINESS USER $10700
ADD TO CART
BUY NOW
PERSONALIZE THIS RESEARCH
Triangulate with your own data
Request your format and definition
Get a deeper dive on a specific application, geography, customer or competitor
10% OFF ON CUSTOMIZATION
Speak To The Analyst
Or Schedule A Call
CONTACT US
+ 1-888-961-4454 Toll – Free
+ 91-788-802-9103 -Int’l
support@researchdive.com